Key result
Epicardial CIED conversion during PEA yields 100% 30-day survival with no lead-related complications.
Why the study?
Transvenous CIED leads are a recognized source of thrombus formation contributing to recurrent pulmonary embolism and progression of CTEPH despite chronic anticoagulation therapy.
Does intravascular lead extraction and epicardial CIED lead placement during pulmonary endarterectomy improve safety and prevent recurrent thrombosis in patients with CTEPH?
Observational (n=9)
No
Does intravascular lead extraction and epicardial CIED lead placement during pulmonary endarterectomy improve safety and prevent recurrent thrombosis in patients with CTEPH?
Epicardial CIED conversion during pulmonary endarterectomy is safe and well tolerated, offering a strategy to reduce recurrent thromboembolic risk in CTEPH patients.
Answers are grounded in this paper and cite their sources.
Should not yet change practice in CTEPH; leaves open whether epicardial conversion during PEA reduces recurrent thrombosis.
Background: Thrombus formation and pulmonary thromboembolism are recognized complications of transvenous cardiac implantable electronic devices (CIEDs).Although the pathophysiology of chronic thromboembolic pulmonary hypertension (CTEPH) is complex, incidental CIED lead thrombi have been confirmed in patients with concomitant CTEPH despite chronic anticoagulation therapy.To reduce the risk of recurrent thrombosis, we performed intravascular lead extraction and epicardial CIED lead placement during pulmonary endarterectomy (PEA) for CTEPH.We present a consecutive case series.Methods: A retrospective medical record review was conducted for the patients undergoing PEA and epicardial CIED lead conversion at our institution between 2020 and 2024.Preoperative, intraoperative and postoperative data were collected.
No takes yet. Share an insight, caveat, or question.
Nemoto et al. (2026) conducted an observational in Chronic thromboembolic pulmonary hypertension (CTEPH) with transvenous CIEDs (n=9). Intravascular lead extraction and epicardial CIED lead placement was evaluated on 30-day survival. Epicardial CIED lead conversion during pulmonary endarterectomy for CTEPH was safe and well tolerated, achieving a 100% 30-day survival rate with no lead-related complications.
Synapse has enriched 10 related papers. Consider them for comparative context: